9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
90 hedge funds and large institutions have $88.8M invested in 9 Meters Biopharma in 2021 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 11 closing their positions.
300% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 11
109% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 11
70% more capital invested
Capital invested by funds: $52.2M → $88.8M (+$36.6M)
58% more funds holding
Funds holding: 57 → 90 (+33)
17% less call options, than puts
Call options by funds: $2.98M | Put options by funds: $3.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TLP
Tri Locum Partners
New York
|
+$8.07M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$3.28M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.76M |
| 4 |
Millennium Management
New York
|
+$2.61M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.68M |
| 2 |
ACM
Altium Capital Management
New York
|
-$1.09M |
| 3 |
SC
Saltoro Capital
Dallas,
Texas
|
-$937K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$678K |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$667K |
NMTR Hedge Fund Activity: Q1 2021 in Review
90 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q1 2021, worth a combined $88.8M — up 70% from $52.2M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new NMTR positions and 11 closed out — a net gain of 33 holders — while 23 added to existing stakes and 11 trimmed.
The largest buyer was Tri Locum Partners, adding an estimated $8.07M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $2.68M sold.
- 90 institutional investors held 9 Meters Biopharma (NMTR) as of Q1 2021, up from 57 in Q4 2020.
- Funds reported $88.8M of 9 Meters Biopharma stock for Q1 2021, up 70% quarter-over-quarter.
- 44 funds opened new 9 Meters Biopharma positions in Q1 2021 and 11 closed out, a net change of +33 holders.
- The largest 9 Meters Biopharma buyer in Q1 2021 was Tri Locum Partners, an estimated $8.07M added.
- The largest 9 Meters Biopharma seller in Q1 2021 was AIGH Capital Management, an estimated $2.68M sold.
Based on aggregated 13F filings for Q1 2021.